Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
University of Vermont, Burlington, USA. william.tutrone@uvm.edu
Actinic keratoses (AKs) are evolving, malignant cutaneous neoplasms. AKs can be treated with physical or destructive methods and with topical therapies. This article is the first in a 2-part series that will review current topical therapeutic options for AKs. Several topical treatment options offer some significant benefit for the alleviation of these lesions. Therapies include 5-fluorouracil, imiquimod, diclofenac, colchicine, and retinoids. The first part of this review will focus on topical 5-fluorouracil and imiquimod.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on